Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • No Records Found
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Invasive Fungal Infections (Emerging market countries listed in Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Accelerate Promotion and Dissemination of Appropriate Atopic Dermatitis Diagnosis, Treatment, and Management Guidance
    Release Date:
    Partner: Japanese Dermatological Association
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Japan
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Pediatric Endocrinology Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease USA
    Growth Hormone Research- United States
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Treatment of acute SARS-CoV-2 infection and management of post-COVID conditions in outpatient settings (European countries)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Topical Hemostasis in Hospital Outpatient and Ambulatory Surgery
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Education for Improving Appropriate Diagnosis and Treatment for Venous Thromboembolism
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Establishment of System for Early Detection of Atrial Fibrillation and Prevention of Cardiogenic Embolism
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Japan
    Atopic Dermatitis and Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Canada
    Advances in Atopic Dermatitis & Alopecia Areata for Community Pharmacists & Managed Care Health Care Professionals
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Bladder Cancer Canada-EMD Serono-Pfizer Quality Improvement Request for Proposals
    Release Date:
    Partner: Bladder Cancer Canada, EMD Serono
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada